ReviewBlood2017
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this papertrialcites it
ReviewBlood2017
Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.